Norditropin Original 30 IU Novo Nordisk | TPT0168
DESCRIPTION - Norditropin Original 30 IU Novo Nordisk
Norditropin is an artificial growth hormone that was originally planned to be used only for medical purposes. But, as is often the case, the pharmacological agent has been used by athletes over time. The growth hormone was developed to treat children who had experienced stunting, so its composition is as safe for the body as possible. The substance gained its popularity among athletes. It can be used to increase the overall endurance of the body, increase the intensity of training and also increase muscle mass.
APPLICATIONS OF Norditropin Original 30 IU Novo Nordisk
The drug has a pronounced effect, which helps stimulate cell and bone growth. During the course, metabolic processes are significantly accelerated, which is particularly important for athletes. The preparation contains synthetic somatropin, which restores the content of natural somatotropin. Thanks to this, athletes:
- increases muscle mass;
- gets rid of fatty tissues;
- gets excellent health and extra strength.
Consumption of the growth hormone forces the body's bone tissue to reorganise, which makes the skeleton more powerful and able to withstand the high loads the bodybuilder is under. At first, after the start of the course, weight loss begins, which is associated with the resorption process, followed by stable growth. It is only possible to determine the appropriate dosage individually, which depends on the state of the body and how it is able to tolerate the components.
We offer you the opportunity to buy Norditropin Original 30 IU Novo Nordisk, which will be promptly delivered throughout the country. If you decide to use the services of our shop, you will definitely receive original and quality products that will ensure guaranteed results.
Any suspicion of an actively growing malignant tumour. Before starting treatment with the growth hormone, it is necessary to ensure that the intracranial tumour is inactive and that the antitumour therapy is complete. Severe patients with complications after surgical interventions on an open chest heart, abdominal cavity, multiple trauma, acute respiratory failure or similar conditions should not be prescribed. The period of pregnancy and breastfeeding. Hypersensitivity to any component of the drug.
In an open randomised clinical trial, an increasing trend in the incidence of middle ear inflammation was noted. However, the increase in the number of infectious otitis did not lead to an increase in the number of ear surgeries compared to the group of patients who received the drug at lower doses. When using Norditropin, it is very rare for adults to notice a decrease in serum thyroxin levels or an increase in the level of thyroxine in the blood. The formation of antibodies to the growth hormone is very seldom detected.
|Active ingredient, mg||10|
|Active ingredient, IU||30|